|
US5354902A
(en)
*
|
1992-10-26 |
1994-10-11 |
Mcneil-Ppc, Inc. |
Stabilized sorbic acid or salt thereof
|
|
WO2003023026A1
(en)
|
2001-09-06 |
2003-03-20 |
Alphavax, Inc. |
Alphavirus replicon vector systems
|
|
EP1608762B1
(en)
|
2003-03-20 |
2014-01-08 |
Alphavax, Inc. |
Improved alphavirus replicons and helper constructs
|
|
PT1751289E
(pt)
|
2004-05-18 |
2009-03-31 |
Alphavax Inc |
Vectores de alfavirais derivados da tc-83, partículas e métodos
|
|
US20090104226A1
(en)
|
2004-05-21 |
2009-04-23 |
Novartis Vaccines And Diagnostics Inc. |
Alphavirus Vectors for Respiratory Pathogen Vaccines
|
|
US7332322B2
(en)
|
2004-09-14 |
2008-02-19 |
Ilya Frolov |
Venezuelan equine encephalitis virus replicons with adaptive mutations in the genome and uses thereof
|
|
WO2007098267A2
(en)
|
2006-02-27 |
2007-08-30 |
The Board Of Regents Of The University Of Texas System |
Pseudoinfectious flavivirus and uses thereof
|
|
EP2049665A2
(en)
|
2006-07-28 |
2009-04-22 |
Applera Corporation |
Dinucleotide mrna cap analogs
|
|
WO2009058911A2
(en)
|
2007-10-31 |
2009-05-07 |
Applied Biosystems Inc. |
Preparation and isolation of 5' capped mrna
|
|
WO2009079185A2
(en)
|
2007-11-26 |
2009-06-25 |
Novartis Vaccines And Diagnostics, Inc. |
Methods of generating alphavirus particles
|
|
EP3100718B1
(en)
|
2008-01-02 |
2019-11-27 |
Arbutus Biopharma Corporation |
Improved compositions and methods for the delivery of nucleic acids
|
|
EP2279254B1
(en)
|
2008-04-15 |
2017-07-05 |
Protiva Biotherapeutics Inc. |
Novel lipid formulations for nucleic acid delivery
|
|
CA2724570A1
(en)
|
2008-05-23 |
2009-11-26 |
Kaja Kiiver |
Expression vector encoding alphavirus replicase and the use thereof as immunological adjuvant
|
|
AU2009303345B2
(en)
|
2008-10-09 |
2015-08-20 |
Arbutus Biopharma Corporation |
Improved amino lipids and methods for the delivery of nucleic acids
|
|
WO2010048536A2
(en)
|
2008-10-23 |
2010-04-29 |
Alnylam Pharmaceuticals, Inc. |
Processes for preparing lipids
|
|
EP3699172A3
(en)
|
2008-11-10 |
2020-11-18 |
Arbutus Biopharma Corporation |
Novel lipids and compositions for the delivery of therapeutics
|
|
EP2391343B1
(en)
|
2009-01-29 |
2017-03-01 |
Arbutus Biopharma Corporation |
Improved lipid formulation for the delivery of nucleic acids
|
|
CA3042927C
(en)
|
2009-05-05 |
2022-05-17 |
Arbutus Biopharma Corporation |
Lipid compositions for the delivery of therapeutic agents
|
|
KR20220038506A
(ko)
|
2009-06-10 |
2022-03-28 |
알닐람 파마슈티칼스 인코포레이티드 |
향상된 지질 조성물
|
|
WO2011082388A2
(en)
|
2009-12-31 |
2011-07-07 |
Medigen, Inc . |
Infectious dna vaccines against chikungunya virus
|
|
EP4481047A3
(en)
|
2010-06-03 |
2025-04-16 |
Alnylam Pharmaceuticals, Inc. |
Biodegradable lipids for the delivery of active agents
|
|
CN103153284B
(zh)
|
2010-07-06 |
2015-11-25 |
诺华股份有限公司 |
含有其pKa值有利于RNA递送的脂质的脂质体
|
|
US10487332B2
(en)
|
2010-07-06 |
2019-11-26 |
Glaxosmithkline Biologicals Sa |
Immunisation of large mammals with low doses of RNA
|
|
CA2804591C
(en)
|
2010-07-06 |
2019-01-22 |
Novartis Ag |
Cationic oil-in-water emulsions
|
|
US9770463B2
(en)
|
2010-07-06 |
2017-09-26 |
Glaxosmithkline Biologicals Sa |
Delivery of RNA to different cell types
|
|
FI4005592T3
(fi)
|
2010-07-06 |
2023-01-13 |
|
Virionin kaltaisia kuljetuspartikkeleita itsereplikoituville rna-molekyyleille
|
|
RS63890B1
(sr)
|
2010-08-31 |
2023-02-28 |
Glaxosmithkline Biologicals Sa |
Mali lipozomi za isporuku rnk koja kodira imunogen
|
|
JP5911870B2
(ja)
|
2010-08-31 |
2016-04-27 |
ノバルティス アーゲー |
免疫原をコードするｒｎａの送達のためのｐｅｇ化リポソーム
|
|
RU2014104090A
(ru)
|
2011-07-06 |
2015-08-20 |
Новартис Аг |
Липосомы с эффективным соотношением n:p для доставки молекул phk
|
|
US11058762B2
(en)
|
2011-07-06 |
2021-07-13 |
Glaxosmithkline Biologicals Sa |
Immunogenic compositions and uses thereof
|
|
JP2014522842A
(ja)
|
2011-07-06 |
2014-09-08 |
ノバルティス アーゲー |
免疫原性組み合わせ組成物およびその使用
|
|
US9636410B2
(en)
|
2011-07-06 |
2017-05-02 |
Glaxosmithkline Biologicals Sa |
Cationic oil-in-water emulsions
|
|
PT2750707T
(pt)
|
2011-08-31 |
2019-01-23 |
Glaxosmithkline Biologicals Sa |
Lipossomas peguilados para distribuição de arn que codifica imunogénio
|
|
CA2853689C
(en)
|
2011-11-04 |
2020-06-30 |
Nitto Denko Corporation |
Method of producing lipid nanoparticles for drug delivery
|
|
PL2790675T3
(pl)
|
2011-12-14 |
2019-12-31 |
Abraxis Bioscience, Llc |
Zastosowanie polimerowych rozczynników do liofilizacji lub zamrażania cząstek
|
|
CA2874490C
(en)
*
|
2012-05-23 |
2021-11-16 |
The Ohio State University |
Tertiary quaternary amine-based cationic lipid nanoparticle compositions and methods of making and methods of using the same
|
|
EP2671591B1
(en)
|
2012-06-08 |
2017-08-09 |
Corden Pharma Brussels |
Process for the preparation of short-chain peptide powders
|
|
US8961995B2
(en)
|
2012-09-20 |
2015-02-24 |
Uab Research Foundation |
Methods and compositions for alphavirus replicons
|
|
WO2014170493A2
(en)
|
2013-04-19 |
2014-10-23 |
Novartis Ag |
Alphavirus vector
|
|
EP3052511A4
(en)
|
2013-10-02 |
2017-05-31 |
Moderna Therapeutics, Inc. |
Polynucleotide molecules and uses thereof
|
|
EP3574923A1
(en)
|
2013-10-22 |
2019-12-04 |
Translate Bio, Inc. |
Mrna therapy for phenylketonuria
|
|
US10842859B2
(en)
|
2014-03-25 |
2020-11-24 |
Yale University |
Uses of parasite macrophage migration inhibitory factors
|
|
EP3061826A1
(en)
|
2015-02-27 |
2016-08-31 |
Novartis AG |
Flavivirus replicons
|
|
US10780054B2
(en)
*
|
2015-04-17 |
2020-09-22 |
Curevac Real Estate Gmbh |
Lyophilization of RNA
|
|
CN113679689B
(zh)
*
|
2015-07-22 |
2023-09-01 |
日东电工株式会社 |
用于纳米粒冷冻干燥物形式的组合物及方法
|
|
DK4276189T3
(da)
|
2015-09-21 |
2026-05-26 |
Trilink Biotechnologies Llc |
Initierende oligonukleotidprimere med kappe til syntesering af 5'-ende RNA'er med kappe
|
|
KR20180074699A
(ko)
|
2015-11-09 |
2018-07-03 |
이뮨 디자인 코포레이션 |
이종 핵산을 발현하는 rna 레플리콘의 발현 및 투여를 위한 레트로바이러스 벡터
|
|
WO2017162266A1
(en)
|
2016-03-21 |
2017-09-28 |
Biontech Rna Pharmaceuticals Gmbh |
Rna replicon for versatile and efficient gene expression
|
|
EP3468537A1
(en)
|
2016-06-14 |
2019-04-17 |
Modernatx, Inc. |
Stabilized formulations of lipid nanoparticles
|
|
EP3471778A4
(en)
|
2016-06-20 |
2020-02-19 |
The Regents of The University of Michigan |
COMPOSITIONS AND METHOD FOR DELIVERING BIOMACROMOLECOLIC ACTIVE SUBSTANCES
|
|
WO2018010815A1
(en)
|
2016-07-15 |
2018-01-18 |
Biontech Rna Pharmaceuticals Gmbh |
Formulation for administration of rna
|
|
ES2993107T3
(en)
|
2016-10-17 |
2024-12-23 |
Janssen Pharmaceuticals Inc |
Recombinant virus replicon systems and uses thereof
|
|
US10487105B2
(en)
|
2016-10-19 |
2019-11-26 |
Arcturus Therapeutics, Inc. |
Trinucleotide MRNA cap analogs
|
|
KR20190093816A
(ko)
|
2016-10-26 |
2019-08-26 |
큐어백 아게 |
지질 나노입자 mRNA 백신
|
|
RU2019119272A
(ru)
|
2016-11-23 |
2020-12-24 |
Гритстоун Онколоджи, Инк. |
Вирусная доставка неоантигенов
|
|
JP7788787B2
(ja)
|
2016-12-05 |
2025-12-19 |
ヤンセン ファーマシューティカルズ，インコーポレーテッド |
遺伝子発現増強のための組成物および方法
|
|
US10383952B2
(en)
|
2016-12-21 |
2019-08-20 |
Arcturus Therapeutics, Inc. |
Ionizable cationic lipid for RNA delivery
|
|
US20190374650A1
(en)
|
2017-02-22 |
2019-12-12 |
The Regents Of The University Of Michigan |
Compositions and methods for delivery of polymer/biomacromolecule conjugates
|
|
EP3589290A4
(en)
|
2017-02-28 |
2020-12-30 |
Arcturus Therapeutics, Inc. |
Translatable molecules and synthesis thereof
|
|
KR102945203B1
(ko)
|
2017-05-08 |
2026-03-31 |
시애틀 프로젝트 코포레이션 |
알파바이러스 신생항원 벡터
|
|
US11015204B2
(en)
|
2017-05-31 |
2021-05-25 |
Arcturus Therapeutics, Inc. |
Synthesis and structure of high potency RNA therapeutics
|
|
KR102636537B1
(ko)
|
2017-05-31 |
2024-02-15 |
울트라제닉스 파마수티컬 인코포레이티드 |
글리코겐 축적 질환 유형 iii에 대한 치료제
|
|
WO2019023566A1
(en)
|
2017-07-28 |
2019-01-31 |
Janssen Vaccines & Prevention B.V. |
METHODS AND COMPOSITIONS FOR PROVIDING IMMUNIZATION AGAINST Heterologous ARNREP
|
|
EP3727444A1
(en)
|
2017-12-18 |
2020-10-28 |
Intervet International B.V. |
Swine influenza a virus vaccine
|
|
KR20200111729A
(ko)
|
2018-01-19 |
2020-09-29 |
얀센 파마슈티칼즈, 인코포레이티드 |
재조합 레플리콘 시스템을 이용한 면역 반응 유도 및 증진
|
|
US12173032B2
(en)
|
2018-07-13 |
2024-12-24 |
The Trustees Of Indiana University |
Recombinant rotavirus expression system and recombinant rotaviruses
|
|
AU2019321186B2
(en)
|
2018-08-17 |
2024-05-23 |
Glaxosmithkline Biologicals Sa |
Immunogenic compositions and uses thereof
|
|
WO2020146700A1
(en)
|
2019-01-10 |
2020-07-16 |
Massachusetts Institute Of Technology |
Lipid nanoparticles
|
|
EP3942050A4
(en)
|
2019-03-19 |
2023-02-22 |
Arcturus Therapeutics, Inc. |
PROCEDURE FOR THE PRODUCTION OF LIPID-COATED RNA NANOPARTICLES
|
|
EP3986452A1
(en)
|
2019-06-18 |
2022-04-27 |
CureVac AG |
Rotavirus mrna vaccine
|
|
GB201908729D0
(en)
|
2019-06-18 |
2019-07-31 |
Imp College Innovations Ltd |
RNA construct
|
|
EP3986458A1
(en)
|
2019-06-20 |
2022-04-27 |
Janssen Sciences Ireland Unlimited Company |
Self-replicating rna molecules for hepatitis b virus (hbv) vaccines and uses thereof
|
|
HRP20241379T1
(hr)
|
2019-09-30 |
2024-12-20 |
Gilead Sciences, Inc. |
Cjepiva za hbv i postupci za liječenje hbv
|
|
WO2021067598A1
(en)
|
2019-10-04 |
2021-04-08 |
Ultragenyx Pharmaceutical Inc. |
Methods for improved therapeutic use of recombinant aav
|
|
US12194089B2
(en)
|
2020-02-04 |
2025-01-14 |
CureVac SE |
Coronavirus vaccine
|
|
EP4114470A4
(en)
|
2020-03-03 |
2024-04-17 |
Arcturus Therapeutics, Inc. |
COMPOSITIONS AND METHODS FOR TREATING ORNITHINE TRANSCARBAMYLASE DEFICIENCY
|
|
JP2023517644A
(ja)
|
2020-03-09 |
2023-04-26 |
アークトゥラス・セラピューティクス・インコーポレイテッド |
コロナウイルスワクチン組成物及び方法
|
|
EP4376883A4
(en)
|
2021-07-30 |
2025-07-16 |
Arcturus Therapeutics Inc |
RNA VACCINES
|